Volume 5, Issue 1 (Spring 2003)                   Advances in Cognitive Sciences 2003, 5(1): 21-26 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sahimi Izadian E, Ahmadi Abhari S A, Sadeghi M, Mesgarpour B. Efficacy and Safety of Trazodone Vs. Nortriptyline Among Middle-Aged Patients With Major Depression . Advances in Cognitive Sciences. 2003; 5 (1) :21-26
URL: http://icssjournal.ir/article-1-129-en.html
Abstract:   (2427 Views)

Objective: The purpose of this study was to assess and compare the efficacy and side effects of nortriptyline vs. trazodone in the treatment of nonpsychotic major depression among Middle-aged patients in a double blind randomized clinical trial.
Method: Thirty patients (40-60 year-old) with nonpsychotic major depressive disorder were selected which have been diagnosed according to DSM-IV diagnostic criteria as well as the Hamilton Depression Rating Scale (HDRS) (minimum score = 20). Cases were randomly assigned into two groups, each consisting of 15 cases. Patients were treated for 8 weeks with either nortriptyline (25-100 mg/day) or trazodone (75-300 mg/day).
Results: Findings showed that both drugs were effective in the treatment of major depressive disorder. Side effects of trazodone and nortriptyline were comparable; however, trazodone causes transient positional dizziness while nortriptyline causes decrease in libido, vaginal dryness, and weight gain.
Conclusion: According to the results of this research, it seems that trazodone is preferred for the patients who can not tolerate the anticholinergic side effects or weight gain. Meanwhile, authors believe that other conditions of the patients should be taken into account while choosing between trazodone and nortriptyline.

Full-Text [PDF 202 kb]   (8991 Downloads)    
Type of Study: Research | Subject: Special
Received: 2002/11/22 | Accepted: 2003/01/21 | Published: 2003/03/21

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb